List of Excipients in API lemborexant
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing lemborexant
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Eisai Inc | DAYVIGO | lemborexant | 62856-405 | FERRIC OXIDE YELLOW | 2035-10-21 |
| Eisai Inc | DAYVIGO | lemborexant | 62856-405 | HYDROXYPROPYL CELLULOSE | 2035-10-21 |
| Eisai Inc | DAYVIGO | lemborexant | 62856-405 | HYPROMELLOSE 2910 | 2035-10-21 |
| Eisai Inc | DAYVIGO | lemborexant | 62856-405 | LACTOSE MONOHYDRATE | 2035-10-21 |
| Eisai Inc | DAYVIGO | lemborexant | 62856-405 | LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE | 2035-10-21 |
| Eisai Inc | DAYVIGO | lemborexant | 62856-405 | MAGNESIUM STEARATE | 2035-10-21 |
| Eisai Inc | DAYVIGO | lemborexant | 62856-405 | POLYETHYLENE GLYCOL 8000 | 2035-10-21 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for lemborexant
Excipient focus: FERRIC OXIDE YELLOW
lemborexant drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Eisai Inc | lemborexant | 62856-405 |
| >Company | >Ingredient | >NDC |
lemborexant drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
lemborexant drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Eisai Inc | lemborexant | 62856-405 |
| >Company | >Ingredient | >NDC |
lemborexant drug variants not containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
lemborexant drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Eisai Inc | lemborexant | 62856-405 |
| >Company | >Ingredient | >NDC |
lemborexant drug variants not containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
lemborexant drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Eisai Inc | lemborexant | 62856-405 |
| >Company | >Ingredient | >NDC |
lemborexant drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
lemborexant drug variants containing LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Eisai Inc | lemborexant | 62856-405 |
| >Company | >Ingredient | >NDC |
lemborexant drug variants not containing LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
lemborexant drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Eisai Inc | lemborexant | 62856-405 |
| >Company | >Ingredient | >NDC |
lemborexant drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 8000
lemborexant drug variants containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Eisai Inc | lemborexant | 62856-405 |
| >Company | >Ingredient | >NDC |
lemborexant drug variants not containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
lemborexant drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Eisai Inc | lemborexant | 62856-405 |
| >Company | >Ingredient | >NDC |
lemborexant drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
lemborexant drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Eisai Inc | lemborexant | 62856-405 |
| >Company | >Ingredient | >NDC |
lemborexant drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
lemborexant drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Eisai Inc | lemborexant | 62856-405 |
| >Company | >Ingredient | >NDC |
lemborexant drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
